In turn, as manifest from the study of Hagemann [32], breast cancer cell-derived MIF might then modulate (pro-invasive) TAM activities as well as induce a broad range of inflammatory processes, including the elevated expression of secondary mediators that may further promote tumourigenesis [14,22]. The gene discussed is MIF; the disease is breast carcinoma.